WO2003095482A3 - Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens. - Google Patents

Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens. Download PDF

Info

Publication number
WO2003095482A3
WO2003095482A3 PCT/FR2003/001387 FR0301387W WO03095482A3 WO 2003095482 A3 WO2003095482 A3 WO 2003095482A3 FR 0301387 W FR0301387 W FR 0301387W WO 03095482 A3 WO03095482 A3 WO 03095482A3
Authority
WO
WIPO (PCT)
Prior art keywords
microbial agents
cyclic peptides
novel cyclic
peptides
relates
Prior art date
Application number
PCT/FR2003/001387
Other languages
English (en)
Other versions
WO2003095482A2 (fr
Inventor
Bernard Romestand
Claude Granier
Philippe Roch
Original Assignee
Centre Nat Rech Scient
Bernard Romestand
Claude Granier
Philippe Roch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient, Bernard Romestand, Claude Granier, Philippe Roch filed Critical Centre Nat Rech Scient
Priority to EP03749919A priority Critical patent/EP1507799A2/fr
Priority to AU2003249396A priority patent/AU2003249396A1/en
Priority to US10/513,637 priority patent/US20060241026A1/en
Publication of WO2003095482A2 publication Critical patent/WO2003095482A2/fr
Publication of WO2003095482A3 publication Critical patent/WO2003095482A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Composés choisis parmi: - les peptides répondant à la formule (I): C(S)-X1-X2-X3-X4-X5-X6-X7-C(S) dans laquelle: - les deux résidus cystéines sont reliés par un pont disulfure, représenté par le symbole C(S), -X1, X2, X3, X4, X5, X6 et X7, représentent des acides aminés choisis parmi une liste déterminée ainsi que: - les dérivés de ces peptides. L'invention a également pour objet les compositions les comprenant ainsi que leur utilisation comme agents anti-microbiens.
PCT/FR2003/001387 2002-05-07 2003-05-05 Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens. WO2003095482A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP03749919A EP1507799A2 (fr) 2002-05-07 2003-05-05 Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens.
AU2003249396A AU2003249396A1 (en) 2002-05-07 2003-05-05 Novel cyclic peptides and use thereof as anti-microbial agents
US10/513,637 US20060241026A1 (en) 2002-05-07 2003-05-05 Novel cyclic peptides and use thereof as anti-microbial agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR02/05704 2002-05-07
FR0205704A FR2839514A1 (fr) 2002-05-07 2002-05-07 Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens

Publications (2)

Publication Number Publication Date
WO2003095482A2 WO2003095482A2 (fr) 2003-11-20
WO2003095482A3 true WO2003095482A3 (fr) 2004-04-08

Family

ID=29286345

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2003/001387 WO2003095482A2 (fr) 2002-05-07 2003-05-05 Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens.

Country Status (5)

Country Link
US (1) US20060241026A1 (fr)
EP (1) EP1507799A2 (fr)
AU (1) AU2003249396A1 (fr)
FR (1) FR2839514A1 (fr)
WO (1) WO2003095482A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100883815B1 (ko) 2007-09-18 2009-02-16 조선대학교산학협력단 트립토판 풍부 모델형 항균 펩타이드와 비자연계 아미노산치환 아나로그 및 그의 용도
AT509267A1 (de) * 2010-01-14 2011-07-15 Apeptico Forschung & Entwicklung Gmbh Organische verbindungen zur regulierung von vektoriellen ionenkanälen
CN104904750A (zh) * 2015-04-21 2015-09-16 漳州康创净化材料有限公司 一种生物抗菌剂、其制备方法及其应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000068265A1 (fr) * 1999-05-10 2000-11-16 The Regents Of The University Of California Defensines theta antimicrobiennnes et methodes d'utilisation correspondantes
WO2001004294A1 (fr) * 1999-07-08 2001-01-18 Centre National De La Recherche Scientifique (Cnrs) Peptides anti-microbiens de mollusques

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000068265A1 (fr) * 1999-05-10 2000-11-16 The Regents Of The University Of California Defensines theta antimicrobiennnes et methodes d'utilisation correspondantes
WO2001004294A1 (fr) * 1999-07-08 2001-01-18 Centre National De La Recherche Scientifique (Cnrs) Peptides anti-microbiens de mollusques

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHARLET ET AL: "Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 271, no. 36, 6 September 1996 (1996-09-06), pages 21808 - 21813, XP002132658, ISSN: 0021-9258 *
MITTA G ET AL: "Differential distribution and defence involvement of antimicrobial peptides in mussel", J.CELL SCIENCE, vol. 113, no. 15, August 2000 (2000-08-01), pages 2759 - 2769, XP002235889 *
MITTA G ET AL: "Original involvement of antimicrobial peptides in mussel innate immunity", FEBS LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 486, no. 3, 15 December 2000 (2000-12-15), pages 185 - 190, XP004337838, ISSN: 0014-5793 *

Also Published As

Publication number Publication date
FR2839514A1 (fr) 2003-11-14
EP1507799A2 (fr) 2005-02-23
AU2003249396A8 (en) 2003-11-11
US20060241026A1 (en) 2006-10-26
AU2003249396A1 (en) 2003-11-11
WO2003095482A2 (fr) 2003-11-20

Similar Documents

Publication Publication Date Title
GB0703060D0 (en) Peptide
WO2003006425A3 (fr) Nouveaux composes convenant comme anti-inflammatoires, immuno-modulateurs et anti-proliferants
ATE420070T1 (de) Kristalline formen von atorvastatin
WO2004041201A3 (fr) Composes de benzofurane, compositions et methodes utilisees pour le traitement et la prophylaxie des infections virales induites par l'hepatite c et des maladies associees
WO2002048157A3 (fr) Imidazolidinones et leurs derives associes, utiles en tant qu'inhibiteurs des proteases ns3 du virus de l'hepatite c
SE0102616D0 (sv) Novel compounds
DE502005006284D1 (de) Keratin-bindende polypeptide
WO2002048116A3 (fr) Inhibiteurs de la protease ns3 du virus de l'hepatite c
NO20044808L (no) Heterosykliske sulfonamider som er hepatitt C virus inhibitorer
DK1086124T3 (da) Nye cyclosporiner
WO2010034105A8 (fr) Composés inhibiteurs de l'hépatite c
DK1483245T3 (da) 5-substituerede alkylaminopyrazolderivater som pesticider
WO2006103101A3 (fr) Moyens pour l'inhibition d'anticorps anti-recepteurs $g(b)1 adrenergiques
MX2009002962A (es) Peptidos antibacterianos y antivirales de actinomadura namibiensis.
TR200503401T1 (tr) Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
ATE425762T1 (de) Mittel zur behandlung von augentrockenheit und damit zusammenhangenden erkrankungen
WO2003095482A3 (fr) Nouveaux peptides cycliques, leur utilisation comme agents anti-microbiens.
CY1109545T1 (el) Συνθεση της (r) και (s)-αμινοκαρνιτινης και παραγωγων που προκυπτουν απο to d- και l- ασπαρτικο οξυ
WO2007066018A3 (fr) Peptides qui peuvent se lier a la proteine nef et leurs applications pharmaceutiques
BR0311590A (pt) Agonistas de brs-3 não-peptìdicos
BR0114709A (pt) Métodos para a preparação de bifenil isoxazol sulfonamidas
ATE326528T1 (de) Alkalische xyloglukanase aus malbranchea
WO2003006659A3 (fr) Represseur transcriptionnel vegetal, facteurs nucleaires proteiques se liant audit represseur, et utilisations associees
WO2002083729A3 (fr) Polypeptides, leurs derives et leurs utilisations
WO2003070769A3 (fr) Composes organiques

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2003749919

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003749919

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2006241026

Country of ref document: US

Ref document number: 10513637

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 10513637

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2003749919

Country of ref document: EP